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1. Introduction
  毬- lactamases are enzymes that are major cause of 
bacterial resistance to the 毬-lactam family of antibiotics 
such as penicillins, cephalosporins, cephamicins and 
carbapenems. These enzymes catalyzes the hydrolysis of the 
amide bond of four membered beta-lactam ring and render 
the antibiotic inactive against its original cellular target, 
the cell wall transpeptidase[1]. On the basis of their primary 
structure, beta-lactamases are grouped into four classes 
A, B, C and D. enzymes of classes A,C and D are active site 
serine enzymes, whereas the class B enzymes are Zn-
metalloenzymes[1,2]. The blaCTX-M type enzymes are a group 
of molecular class A extended spectrum 毬-lactamases that 
exhibit an overall preference for cefotaxime and ceftriaxone, 
than against ceftazidime, and a higher susceptibility to 
tazobactam than to clavulanate[3].
  In recent years CTX-M ESBLs have very rapidly 
disseminated and are now frequently reported from various 
countries[3-7]. In India, the very first report of the presence 
of CTX-M came from New Delhi where only bacterial 
isolates from year  2000 were investigated and reported as 
CTX-M-15 type[8]. Subsequently, we performed a systematic 
survey studying a total of 130 non-duplicate third-
generation cephalosporin-resistant Enterobacteriaceae 
collected during 2003-2005 and found high prevalence 
(73%) of CTX-M-15 and again all producing CTX-M[9]. 
Objective: To delineate the frequency of occurrence of blaCTX-M, blaTEM, and blaSHV in 
Enterobacteriaceae from North-Indian tertiary hospital. Methods: A random collection of a 
subset of 45 Escherichia coli (E. coli) and 28 Klebsiella pneumoniae (K. pneumoniae) that was 
resistant to a third generation cephalosporin and obtained during 2007-2008 was selected for 
detailed screening for blaCTX-M, blaTEM, and blaSHV by monoplex PCRs. The isolates demonstrating 
the presence of blaCTX-M alleles were characterized for the specific CTX-M-genogroup by using 
a multiplex PCR. Results: Resistance to cefoperazone, ceftazidime, ceftriaxone, cefotaxime, 
cefoxitin and piperacillin was 100% each in K. pneumoniae isolates, whereas these resistance-
rates for E. coli isolates were 93.1%, 83.8%, 91.9%, 93.6%, 97.3% and 97.1%, respectively. 
Concomitant resistance to aminoglycosides, quinolones and aztreonam was also noticed. Presence 
of any of the bla genes (blaCTX-M, blaTEM, and blaSHV) was noticed in a total of 28 (38.4%) isolates 
of the 73 isolates studied. Many isolates demonstrated occurrence of these genes in various 
combinations. blaCTX-M, blaTEM, and blaSHV were noticed in 28.8%, 10.9% and 13.7% isolates, 
respectively. Multiplex PCR in blaCTX-M harboring isolates demonstrated the presence of CTX-M- 
Genogroup-1 and sequencing for the specific CTX-M-type revealed presence of CTX-M-15 type. 
RAPD typing showed wide diversity in isolates. Conclusions: This is amongst the premier report 
describing the simultaneous occurrence of blaTEM, blaSHV, and blaampC in Indian Enterobacteriaceae 
and that wider dissemination of these genes, as demonstrated by diversity of isolates, raises 
concern and emphasizes a need for extensive search for the presence of these gene pools in 
Indian subcontinent. 
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During those years, Walsh et al [10] also reported a similar 
high occurrence of blaCTX-M in Indian Enterobacteriaceae and 
interestingly all were reported as CTX-M-15 type. Moreover, 
they also looked for the occurrence of blaTEM and blaSHV in the 
isolates and reported that TEM was the most common ESBL 
followed by CTX-M during that time. Those reports raised a 
high concern at our institution and institutional antibiotics 
prescribing policy was re-defined among clinicians. 
Following 3 years of implementation of re-defined policy 
we planned this study to find out its impact and existing 
prevalence of CTX-M in Enterobacteriaceae. Moreover, we 
also planned to look for the occurrence TEM and SHV beta-
lactamases in the isolates since the systematic reports 
looking for the simultaneous occurrence of these ESBL genes 
are lacking in Indian literature. 
2. Materials and methods
  The present prospective study was carried out in the 
department of Microbiology of Jawaharlal Nehru Medical 
College & Hospital, Aligarh Muslim University, U.P., India, 
over a period from July 2007 to July 2008.
2.1. Clinical samples and bacterial collection
  During July 2007 - July 2008, a total of 9 423 clinical 
samples were subjected to our department for routine 
culture and antimicrobial susceptibility testing. Of these, 
2 367 samples yielded growths of gram-negative bacterial 
species. A subset of 73 bacterial isolates (45 E. coli and 
28 K. pneumoniae) that were found resistant to any of the 
third generation cephalosporins was selected for detailed 
screening for blaCTX-M, blaTEM and blaSHV. All these 73 
isolates were identified by the standard microbiological 
techniques[11,12].
2.2. Antimicrobial susceptibility and MIC testing
  Antimicrobial susceptibility testing was carried out on 
Mueller Hinton agar (HiMedia, India) by the standard 
disk diffusion method as per Clinical Laboratory Standard 
Institute (CLSI; formerly NCCLS) guidelines[13]. E. coli 
ATCC 25922 and P. aeruginosa ATCC 27853 were used as 
controls. The antibiotics used and their concentrations (毺g) 
were: cefotaxime (30), ceftazidime (30), cefoperazone (75), 
ceftriaxone (30), cefepime (30), cefoxitin (30), aztreonam (30), 
gentamicin (10), ciprofloxacin(1), imipenem (10), piperacillin 
(100), piperacillin/tazobactam (100/10), cephoperazone/
sulbactam (75/10), ceftazidime-clavulanic acid (30/20), 
and amoxicillin-clavulanic acid (30/20). The antibiotics 
disks used were purchased from HiMedia Lab. Ltd., India. 
Minimum inhibitory concentrations (MICs) for ceftazidime 
and cefotaxime were noted according to CLSI guidelines[14].
2.3. Phenotypic detection of extended-spectrum beta-
lactamases (ESBLs)
  ESBL detection by disc synergy test using amoxicillin-
clavulanate and piperacillin-tazobactam as ESBL inhibitors, 
in all 73 isolates, was performed as described previously[15] . 
Briefly, the test inoculum (0.5 McFarland turbidity) was 
streaked on Mueller-Hinton agar. A disc of amoxicillin-
clavulanate (20/10 毺g) was placed at a distance of 30 mm, 
center to center, from cefotaxime (30 毺g) and ceftazidime 
(30 毺g). A parallel experimentation was done using 
piperacillin-tazobactam, in place of co-amoxyclav disc, 
as described previously[15] for comparative analysis of 
phenotypic ESBL detection.
2.4. Detection of blaCTX-M by PCR
  All 73 isolates were initially screened for the presence 
of blaCTX-M alleles by PCR using a set of universal 
primers responsible to yield an amplicon of 593 bp. The 
forward and reverse primers used for this monoplex 
PCR were 5’-ATGTGCAGYACCAGTAARGT-3’ and 5’-
TGGGTRAARTARGTSACCAGA-3’, respectively and the 
cycling conditions were: initial denaturation at 94 曟 for 
7 min; 35 cycles of 94 曟 for 50 sec; 50 曟 for 40 sec and 
72 曟 for 1 min; and a final elongation at 72 曟 for 5 min. 
Subsequently, all bacterial isolates demonstrating the 
presence of blaCTX-M alleles were characterized for the 
specific CTX-M-genogroup by using a multiplex PCR 
protocol of Woodford et al [16].
2.5. Sequencing of representative isolates
  Sequencing in the representative isolates was performed by 
courtesy of Chromous Biotech Lab Ltd, Bangalore, India. 
2.6. Detection of blaTEM and blaSHV by PCR
  The forward and reverse primers used for respective 
detection of blaTEM and blaSHV 5’-KACAATAACCCTGRTAAA-3’ 
& 5 ’ - A G T A T A T A T G A G T A A A C T T G G - 3 ’ , a n d  5 ’ -
TTTATCGGCCYTCACTCAAGG-3’&5’-GCTGCGGGCCGGATAACG-3’, 
respectively, as used in our previous studies[17]. The cycling 
conditions for detection of blaTEM and blaSHV were the same 
as described here: initial denaturation at 95 曟 for 15 min; 
35 cycles of 94 曟 for 1 min; 58 曟 for 2 min and 72 曟 for 
3 min; and a final elongation at 72 曟 for 10 min.
2.7. RAPD-PCR typing
  Epidemiological typing of the isolates by RAPD PCR was 
done, as described previously, to ascertain any specific 
clone circulating in the survey population[9, 18]. 
3. Results
3.1. Clinical specimens and bacterial isolates
  During the study period of one year, a total of 2 367 
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specimens yielded growths of gram-negative bacterial 
species and a subset of 45 E. coli and 28 K. pneumoniae 
that were found resistant to any of the third generation 
cephalosporins was selected for detailed screening 
for blaCTX-M, blaTEM and blaSHV. These 73 non-repeat 
cephalosporin-resistant bacterial isolates were obtained 
from pus (n=20), urine (n=19), blood (n=15), throat swabs 
(n=4), cervical swabs (n=7), stool (n=5), sputum (n=2) and 
cerebrospinal fluid (n=1).
3.2. Antibiotics resistance and MIC testing
  The detailed antibiotic resistance rates and MIC-
distribution results are shown in Table 1 & 2, respectively. 
It was interesting to note that all (100%) the K. pneumoniae 
isolates randomly selected for this study were found resistant 
to cefoperazone, ceftazidime, ceftriaxone, cefotaxime, 
cefoxitin and piperacillin. The above resistance-rates 
for E. coli isolates were 93.1%, 83.8%, 91.9%, 93.6%, 97.3% 
and 97.1%, respectively. Apart from the resistance to 
cephalosporins the isolates also demonstrated concomitant 
high resistance to aminoglycosides, quinolones and 
aztreonam (Table 1). 
3.3. Phenotypic ESBL detection
  ESBLs were phenotypically detected in 61.7% (45/73) isolates 
using piperacillin/tazobactam in synergy test, however 51.2% 
(41/73) isolates were detected by using co-amoxyclav as an 
ESBL inhibitor.
3.4. Detection of bla genes
  Out of 73 isolates studied, presence of any of the bla genes 
(blaCTX-M, blaTEM, and blaSHV) was noticed in a total of 28 (38.4%) 
isolates. Occurrence of single bla gene viz. blaCTX-M, blaTEM, 
or blaSHV, was noticed in 11, 2, & 3 isolates, respectively. 
However, many isolates demonstrated occurrence of these 
genes in various combinations viz. blaCTX-M + blaTEM, blaCTX-M 
+ blaSHV, blaTEM + blaSHV  in 4, 6, & 2 isolates, respectively. 
None of the isolates showed the presence of all these three 
bla genes (blaCTX-M + blaTEM + blaSHV) in a single bacterial cell.
3.5. Detection of blaCTX-M, blaTEM, and blaSHV 
  blaCTX-M was noticed in a total of 28.8% (21/73) isolates 
whereas blaTEM and blaSHV was noticed in 10.9% and 13.7% 
isolates, respectively. The frequency of occurrence of these 
bla genes was higher in K. pneumoniae as opposed to E. coli 
(kindly refer to Table 3 for detailed description of results). 
Further analyses of the isolates demonstrating blaCTX-M by 
monoplex PCR revealed the presence of CTX-M genoroup-1 
by multiplex PCR.
3.6. Typing of isolates by RAPD-PCR
  RAPD-PCR typing demonstrated great diversity in isolates 
and no predominant clone was identified (Figure 1). The 
isolates could not be grouped into clusters because of 
unique banding patterns. No gross banding difference was 
noticed between two RAPD-PCR experiments.
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Figure 1. RAPD-PCR typing demonstrating diversity in isolates.
Table 1 
Percent antibiotic resistance rates of E. coli and K. pneumoniae isolates 
against various antibiotics tested.
Antibiotics tested
%Resistance
E. coli (n=45) K. pneumoniae (n=28)
Piperacillin 97.14 100.00
Piperacillin/Tazobactam 27.03   61.90
Cefoperazone-Sulbactam 44.44   64.71
Cefoperazone 93.10 100.00
Ceftazidime-clavulanic acid 16.67   27.78
Ceftazidime 83.78 100.00
Amoxyclav 72.97   85.71
Ceftriaxone 91.89 100.00
Cefotaxime 93.55 100.00
Cefoxitin 97.30 100.00
Cefepime 96.67   92.86
Aztreonam 80.00   89.30
Gentamicin 71.10   64.30
Ciprofloxacin 68.90   64.30
Imipenem   0.00     0.00
Table 2 
MICs to ceftazidime and cefotaxime in E. coli and K. pneumoniae 
isolates.
MICs (mg/L)
%  K. pneumoniae isolates 
resistant to
%  E. coli isolates resistant 
to
Ceftazidime Cefotaxime Ceftazidime Cefotaxime
>16   3.45 - - -
>32   3.45 -   5.71   4.65
>64   6.90 22.22   8.57   6.98
>128 31.03 11.11 31.43 18.60
>256 31.03 44.44 17.14 16.28
>512 17.24 22.22   8.57   9.30
>1024   6.90 -   8.57 44.11
Table 3 
Distribution of various beta-lacatmases among Indian isolates of E. 
coli and K. pneumoniae screened in this study [n(%)].
Isolates (n)
Genotypes present in No. of isolates
CTX-M TEM SHV
E. coli (45) 10 (4.5) 3 (6.7) 3 (6.7)
K. pneumoniae (28)   11 (39.2)   5 (17.9)   7 (25.0)
Total (73)   21 (28.8)   8 (10.9) 10 (13.7)
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4. Discussion
  The prevalence and type of ESBLs may vary from one 
geographic region to other. For e.g. in China TEM-type were 
found to be most prevalent ESBLs among the E. coli (ESBL 
producing strains) followed by SHV and then CTX-M-type 
enzymes[19]. Another report from Canada shows SHV as main 
group of ESBLs in E. coli and only 6% of ESBL producers 
were found to carry blaTEM  and blaCTX-M[20]. Group 2 CTX-M 
enzymes are the most prevalent CTX-M enzymes in parts of 
South America and of Israel[21] while group 9 enzymes were 
found to be prevalent in Spain[22].
  First CTX-M-9 (Group 9) producing Klebsiella was isolated 
in UK in 2000[23]. Then CTX-M-26 from group 25/26 was 
recovered from Birmingham[24]. Group 1 (CTX-M-9,-14 
and -15) producing isolates were found in both community 
and hospitals in New York[25]. A surveillance study in U.K. 
showed wide scattering of CTX-M-15 producing E. coli[26]. 
In India, till date, CTX-M has been reported to be the most 
prevalent ESBL[9]. However, the reports simultaneously 
looking for blaCTX-M, blaTEM, and blaSHV are fragmentary from 
India. In the present collection of Indian Enterobacteriaceae 
of 2007-2008, we found CTX-M as the most prevalent 
(28.8%) ESBL followed by SHV (13.7%) and TEM (10.9%). The 
frequency of occurrence of these bla genes was higher in K. 
pneumoniae than in E. coli isolates. In our earlier collection 
of 2003-2005[9], we already reported a higher occurrence of 
blaCTX-M in Indian Enterobacteriaceae however, we couldn’t 
look for blaTEM and blaSHV in those isolates. The present 
study is significant since it reports the presence of CTX-M 
enzymes as the most prevalent ESBL-types in contrast to 
Walsh et al [10]. who reported TEM as the most prevalent 
enzymes prior to year 2000. The present study clearly 
demonstrates the drastic change in the gene pool in Indian 
Enterobacteriaceae.
  Infections caused by ESBL producing strains are increasing 
in frequency however only few PCR based surveys of ESBL 
producing strains have been performed and reported till 
now from India[9, 10]. Recently CTX-M-1-type was reported 
(with a prevalence of 58.3%) from South India[27] however in 
our previous study[9], in which we included 19 isolates from 
South India (Hubli), we got only CTX-M-15-type from South 
Indian isolates also.
  A recent study also reported the presence of blaCTX-M-28 
for the first time from India[28].  In reaction to these reports 
describing the occurrence of new CTX-M types in Indian 
Enterobacteriaceae we also planned this study and screened 
our isolates by multiplex PCR to look for the presence of 
specific CTX-M-genogroups in our location and found 
all isolates belonging to genogroup-1. Sequencing of the 
representative isolates demonstrated the presence of CTX-
M-15 type (GenBank Accession No. GQ117123). 
  To date, in addition to 150 OXA type, 55 SHV-type and 
135 TEM-type, more than 70 CTX-M type ESBLs have been 
identified (http://www.lahey.org/studies/webt.htm).
  Occurrence or association of more than one 毬-lactamase 
within the same isolate has been reported[8, 25]. In the 
present collection of Indian Enterobacteria not only we 
noticed the occurrence of these bla genes singly, but 
also in various combinations, which denotes their wider 
dissemination probably due to involvement of genetic 
elements in mobilization of these genes. In this study, only 
38.4% of the isolates demonstrated the presence of bla genes 
as opposed to that of phenotypic detection in 61.7% isolates 
by piperacillin-tazobactam synergy test and we speculate 
that some other ESBL genes, probably OXA-type and others, 
are also prevalent in Indian bacteria which we even could 
not look for in this collection.
  Bacteria are noteworthy for their remarkable ability to 
adapt changes in their environment. Although mutation 
has an important role to play in the evolution of antibiotic 
resistance, the predominant factor for escalation of antibiotic 
resistance is the acquisition of antibiotic resistance genes. 
The antimicrobial resistance of gram-negative organism has 
built up progressively during the last few decades, leading 
to increased incidence of outbreaks of infections due to 
existence of multi-resistant bacteria. Resistant bacterial 
strains are spreading rapidly, where they have chance to 
come in close contact with other bacteria, sharing resistance 
genetic material and thus spreading the antimicrobial 
resistance phenotypes.
  In infections caused by the same bacterial clone 
(monoclonal outbreak) or by a few bacterial clones 
(oligoclonal outbreak), the pathogen usually passes 
horizontally (from patient to patient), while infections 
originated by various clones of the same species (polyclonal 
outbreaks) are usually caused by the intensive selective 
pressure imposed by antibiotic use[29]. On comparing the 
prevalence of ESBLs (CTX-M) in our collection of 2003-
2005 with this collection of 2007-2008, we noticed drastic 
reduction from 73% to 28.8% which could be the impact 
of changes in the antibiotics prescribing habits at our 
institution. However, based on the RAPD-PCR typing, great 
diversity of the isolates was noticed and emphasize the 
need to re-analyze and implement strict national antibiotics 
prescribing policies to minimize the selective pressure.
  In nutshell, CTX-M enzymes are the most prevalent ESBLs 
in our region (Aligarh) followed by SHV and TEM. More 
alarming is the detection of combination of these bla genes 
in recent collection. Moreover, wider dissemination of these 
genes as demonstrated by diversity of isolates raises concern 
and emphasizes a need for extensive search for the presence 
of these genes in Indian subcontinent and also to implement 
strict national antibiotics policies to restrict the spread of 
these resistance bugs.
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